CareStart Covid-19 Antigen Test
To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical. Particularly, the identification of subclinical or asymptomatic cases is important to reduce or stop the infection because these individuals may transmit the virus. As an intended point-of-care (POC) designated test with a 10 min processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Features
- Detect SARS-CoV-2 nucleocapsid protein antigen with ultra high performance
- Identify acute infection with 88.4% sensitivity and 100% specificity
- EUA granted by FDA
- No equipment required
- Rapid results within 10 minutes
- Minimally invasive specimen collection (nasopharyngeal swabs) Intended at POC setting (i.e., in patient care settings) by medical professionals
Note for Healthcare Providers: the CARES Act reimburses each test (CARES Act Category 1 CPT codes 86328 and 86769). If providers are out of network, private insurers are required to reimburse.
